Advertisement
Hosting the call will be Mr. Colin Zhao, Chief Executive Officer, and Mr.Tristan Kuo, Chief Financial Officer. The Company plans to distribute itsearnings press release prior to the call.
Advertisement
To participate in the live conference call, please dial the followingnumber five to ten minutes prior to the scheduled conference call time:877-409-5468. International callers should dial +1-702-894-2400. The pass codefor the call is 64404888.
If you are unable to participate in the call at this time, a replay willbe available for 14 days starting on Wednesday, March 24, 2010 at 10:00 a.m.EDT. To access the replay, dial 800-642-1687, international callers shoulddial +1-706-645-9291. The conference pass code is 64404888.
About China Biologic Products, Inc.
China Biologic Products, Inc. (the "Company"), through its indirectmajority-owned subsidiaries, Shandong Taibang Biological Products Co. Ltd. andGuiyang Dalin Biologic Technologies Co., Ltd, and its equity investment inXi'an Huitian Blood Products Co., Ltd., is currently the largestnon-state-owned plasma-based biopharmaceutical company in China. The Companyis a fully integrated biologic products company with plasma collection,production and manufacturing, research and development, and commercialoperations. The Company's plasma-based biopharmaceutical products areirreplaceable during medical emergencies, and are used for the prevention andtreatment of various diseases. The Company sells its products to hospitals andother healthcare facilities in China.For more information, please contact: Company Contact: Mr. Y. Tristan Kuo Chief Financial Officer China Biologic Products, Inc. Tel: +86-538-6202206 Email: [email protected] Web: http://www.chinabiologic.com Investor Relations Contact: Ms. Lei Huang, Account Manager CCG Investor Relations Phone: +1-646-833-3417 Email: [email protected] Web: http://www.ccgirasia.com Mr. Crocker Coulson, President Phone: +1-646-213-1915 Email: [email protected]
SOURCE China Biologic Products, Inc.
